10-Q Filing

ABBVIE INC. CIK: 1551152 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001551152-21-000031`
Period End Date	20210930
Filing Date	20211102
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	abbv-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 80 Cash Flow Statement 82 Stockholders Equity 37 Comprehensive Income 52

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.18B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.80B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.79B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.45B	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	33.97M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$30.00M	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	27.01M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$67.00M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$9.28B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$8.82B	USD	Point-in-time
Inventories	`InventoryNet`	$3.31B	USD	Point-in-time
Inventories	`InventoryNet`	$3.09B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$3.56B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.33B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.96B	USD	Point-in-time
Investments	`LongTermInvestments`	$272.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$293.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.13B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.25B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$77.46B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$82.88B	USD	Point-in-time
Goodwill	`Goodwill`	$33.12B	USD	Point-in-time
Goodwill	`Goodwill`	$32.30B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.85B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.75B	USD	Point-in-time
Total assets	`Assets`	$148.86B	USD	Point-in-time
Total assets	`Assets`	$150.56B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$16.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$34.00M	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$8.47B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$6.66B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.16B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$21.86B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.53B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.66B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$77.55B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$74.05B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.65B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.60B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$27.61B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$29.10B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,801,781,004 shares issued as of September 30, 2021 and 1,792,140,764 as of December 31, 2020	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,801,781,004 shares issued as of September 30, 2021 and 1,792,140,764 as of December 31, 2020	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 33,974,112 shares as of September 30, 2021 and 27,007,945 as of December 31, 2020	`TreasuryStockValue`	$2.26B	USD	Point-in-time
Common stock held in treasury, at cost, 33,974,112 shares as of September 30, 2021 and 27,007,945 as of December 31, 2020	`TreasuryStockValue`	$3.02B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$17.38B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.11B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.05B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.60B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.16B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.12B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.08B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.55B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$27.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$21.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.58B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.29B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$148.86B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$150.56B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$12.90B	USD	1 Quarter
Net revenues	`Revenues`	$41.31B	USD	3 Qtrs
Net revenues	`Revenues`	$31.95B	USD	3 Qtrs
Net revenues	`Revenues`	$14.34B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.39B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$10.70B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.05B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$13.13B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.07B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.09B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.85B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.08B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.71B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.67B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.67B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$5.26B	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$898.00M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$45.00M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$557.00M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$390.00M	USD	1 Quarter
Other operating expense, net	`OtherOperatingIncomeExpenseNet`	-	USD	1 Quarter
Other operating expense, net	`OtherOperatingIncomeExpenseNet`	$-500.00M	USD	1 Quarter
Other operating expense, net	`OtherOperatingIncomeExpenseNet`	$-432.00M	USD	3 Qtrs
Other operating expense, net	`OtherOperatingIncomeExpenseNet`	-	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$10.04B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$9.65B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$28.46B	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$24.34B	USD	3 Qtrs
Operating earnings	`OperatingIncomeLoss`	$4.31B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$12.85B	USD	3 Qtrs
Operating earnings	`OperatingIncomeLoss`	$3.25B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$7.61B	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-585.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.66B	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-620.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.81B	USD	3 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-54.00M	USD	3 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-20.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-12.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-35.00M	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-21.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.28B	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-115.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-989.00M	USD	3 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.91B	USD	3 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.69B	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.72B	USD	3 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.50B	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$508.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$187.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.21B	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$321.00M	USD	3 Qtrs
Net earnings	`ProfitLoss`	$4.58B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$2.31B	USD	1 Quarter
Net earnings	`ProfitLoss`	$7.50B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.18B	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	3 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	3 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$3.18B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$7.50B	USD	3 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.31B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.58B	USD	3 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.78	USD	3 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$1.78	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$4.21	USD	3 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$1.30	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.78	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$4.19	USD	3 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$2.77	USD	3 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.29	USD	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.63B	shares	3 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	3 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	3 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.64B	shares	3 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.77B	shares	1 Quarter

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$4.58B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$2.31B	USD	1 Quarter
Net earnings	`ProfitLoss`	$7.50B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.18B	USD	1 Quarter
Depreciation	`Depreciation`	$175.00M	USD	1 Quarter
Depreciation	`Depreciation`	$439.00M	USD	3 Qtrs
Depreciation	`Depreciation`	$223.00M	USD	1 Quarter
Depreciation	`Depreciation`	$630.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.10B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.90B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.91B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$3.97B	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-498.00M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-153.00M	USD	3 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.08B	USD	3 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.45B	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$563.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$617.00M	USD	3 Qtrs
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$1.22B	USD	3 Qtrs
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$1.03B	USD	3 Qtrs
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	-	USD	3 Qtrs
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	$68.00M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$114.00M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-491.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$572.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$574.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$193.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$30.00M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$462.00M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-190.00M	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.45B	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.90B	USD	3 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-628.00M	USD	3 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-298.00M	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.70B	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.73B	USD	3 Qtrs
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$38.14B	USD	3 Qtrs
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$1.07B	USD	3 Qtrs
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$837.00M	USD	3 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$519.00M	USD	3 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$600.00M	USD	3 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$73.00M	USD	3 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$47.00M	USD	3 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.46B	USD	3 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$88.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-223.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.38B	USD	3 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-36.93B	USD	3 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.20B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.00B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00B	USD	3 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.41B	USD	3 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$5.66B	USD	3 Qtrs
Debt issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$20.00M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$5.62B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$6.95B	USD	3 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$803.00M	USD	3 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$682.00M	USD	3 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$109.00M	USD	3 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$169.00M	USD	3 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$480.00M	USD	3 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$212.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$22.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$28.00M	USD	3 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.81B	USD	3 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-12.70B	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-69.00M	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-32.00M	USD	3 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-32.03B	USD	3 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.73B	USD	3 Qtrs
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.89B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.18B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.89B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.18B	USD	Point-in-time
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	$23.98B	USD	3 Qtrs
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	-	USD	3 Qtrs

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.58B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.29B	USD	Point-in-time
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$3.18B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$7.50B	USD	3 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.31B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.58B	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$176.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$337.00M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-53.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-39.00M	USD	3 Qtrs
Dividends declared	`DividendsCommonStockCash`	$2.10B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$6.95B	USD	3 Qtrs
Dividends declared	`DividendsCommonStockCash`	$2.32B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$5.96B	USD	3 Qtrs
Common shares and equity awards issued for acquisition of Allergan plc	`StockIssuedDuringPeriodValueAcquisitions`	$24.41B	USD	3 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$6.00M	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$682.00M	USD	3 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$803.00M	USD	3 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$20.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$180.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$771.00M	USD	3 Qtrs
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$201.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$760.00M	USD	3 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$6.00M	USD	3 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$-5.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$19.00M	USD	3 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.73B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.58B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.29B	USD	Point-in-time

Comprehensive Income 52 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$4.58B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$2.31B	USD	1 Quarter
Net earnings	`ProfitLoss`	$7.50B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.18B	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$15.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(8) for the three months and $(32) for the nine months ended September 30, 2021 and $15 for the three months and $11 for the nine months ended September 30, 2020	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$512.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$11.00M	USD	3 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(8) for the three months and $(32) for the nine months ended September 30, 2021 and $15 for the three months and $11 for the nine months ended September 30, 2020	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-794.00M	USD	3 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-32.00M	USD	3 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(8) for the three months and $(32) for the nine months ended September 30, 2021 and $15 for the three months and $11 for the nine months ended September 30, 2020	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$726.00M	USD	3 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(8) for the three months and $(32) for the nine months ended September 30, 2021 and $15 for the three months and $11 for the nine months ended September 30, 2020	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-361.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-8.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$123.00M	USD	3 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $51 for the three months and $123 for the nine months ended September 30, 2021 and $(85) for the three months and $(125) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$444.00M	USD	3 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$51.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $51 for the three months and $123 for the nine months ended September 30, 2021 and $(85) for the three months and $(125) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$184.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-125.00M	USD	3 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $51 for the three months and $123 for the nine months ended September 30, 2021 and $(85) for the three months and $(125) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-314.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-85.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $51 for the three months and $123 for the nine months ended September 30, 2021 and $(85) for the three months and $(125) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-455.00M	USD	3 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $17 for the three months and $50 for the nine months ended September 30, 2021 and $10 for the three months and $37 for nine months ended September 30, 2020	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-67.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $17 for the three months and $50 for the nine months ended September 30, 2021 and $10 for the three months and $37 for nine months ended September 30, 2020	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-134.00M	USD	3 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $17 for the three months and $50 for the nine months ended September 30, 2021 and $10 for the three months and $37 for nine months ended September 30, 2020	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-35.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-50.00M	USD	3 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $17 for the three months and $50 for the nine months ended September 30, 2021 and $10 for the three months and $37 for nine months ended September 30, 2020	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-196.00M	USD	3 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-10.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-17.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-37.00M	USD	3 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$16.00M	USD	3 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $13 for the three months and $16 for the nine months ended September 30, 2021 and $(9) for the three months and $(13) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$57.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $13 for the three months and $16 for the nine months ended September 30, 2021 and $(9) for the three months and $(13) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$115.00M	USD	3 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$13.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-9.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $13 for the three months and $16 for the nine months ended September 30, 2021 and $(9) for the three months and $(13) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-68.00M	USD	3 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $13 for the three months and $16 for the nine months ended September 30, 2021 and $(9) for the three months and $(13) for the nine months ended September 30, 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-57.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-13.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$176.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$337.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-53.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-39.00M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.92B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.46B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.49B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.13B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$4.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.00M	USD	3 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$2.48B	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$3.13B	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$4.92B	USD	3 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$7.46B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.